Jieyu Xing

School of Pharmaceutical Sciences,
Center for Cellular & Structural Biology

Sun Yat-sen University

BIOGRAPHY

Jieyu Xing has not added Biography.

If you are Jieyu Xing and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

A targeted IL-15 fusion protein with potent anti-tumor activity.

Cancer biology & therapy , 2015 | Pubmed ID: 26176990

A single-domain antibody-linked Fab bispecific antibody Her2-S-Fab has potent cytotoxicity against Her2-expressing tumor cells.

AMB Express Dec, 2016 | Pubmed ID: 27112931

BiHC, a T-Cell-Engaging Bispecific Recombinant Antibody, Has Potent Cytotoxic Activity Against Her2 Tumor Cells.

Translational oncology Oct, 2017 | Pubmed ID: 28797938

Site-specific PEGylation of an anti-CEA/CD3 bispecific antibody improves its antitumor efficacy.

International journal of nanomedicine , 2018 | Pubmed ID: 29881272

INSTITUTIONS

Sun Yat-sen University

JOVE ARTICLES

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Yanlan Wang^1,2,

Jiayu Liu^1,2,

Haitao Pan^1,2,

Jieyu Xing^1,2,

Xiaoqiong Wu^1,2,

Qing Li^1,2,

Zhong Wang^1,2

¹School of Pharmaceutical Sciences, Sun Yat-Sen University,

²Center for Cellular & Structural Biology, Sun Yat-Sen University

Cancer Research

政策

使用条款

隐私

联系我们

向图书馆推荐

JoVE 新闻简报

科研

JoVE Journal
技术专题合集
JoVE Encyclopedia of Experiments
档案

教育

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教师资源中心
Faculty Site

发表

概述
发表流程
编辑部
范围和政策
同行评审
常见问题
提交稿件

图书馆员

概述
客户评价
订阅
访问权限
资源
图书馆咨询委员会
常见问题

关于 JoVE

概述
管理层
博客
JoVE Help Center

Jieyu Xing

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}School of Pharmaceutical Sciences,Center for Cellular & Structural Biology

Sun Yat-sen University

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

School of Pharmaceutical Sciences,
Center for Cellular & Structural Biology